MarketScreener Editorial Features Galapagos NV Euronext Bruxelles
Equities
GLPG
BE0003818359
End-of-day quote
Other stock markets
|
||
- | - |
31/05 | Galapagos, Adaptimmune to Jointly Develop Head, Neck Cancer Treatment | MT |
31/05 | Galapagos, Adaptimmune Therapeutics Team Up to Evaluate Head and Neck Cancer Drug | MT |
MarketScreener Editorial Features
Global markets live: HSBC, Baidu, Exxon Mobil, Geely, Tesla... | January 02, 2024 at 09:10 pm IST | |
Global markets live: BP, Pfizer, Amgen, Pinterest, VF Corp... | October 31, 2023 at 09:43 pm IST | |
Global markets live: Samsung, Clariant, AstraZeneca, Amazon, Merck... | November 23, 2021 at 10:19 pm IST |
- Stock Market
- Equities
- GLPG Stock
- GLPG Stock
- News Galapagos NV
- MarketScreener Editorial Features